Dental Practice Exit Planning and M&A advisory

The problem

Why this matters

The most expensive mistake dental practice owners make

Most practice owners only begin thinking seriously about their sale when they are already emotionally ready to leave. That is too late. The buyers, the brokers and the valuers have seen thousands of practices. They know exactly what to look for – and what to use to drive your price down.

The difference between a well-prepared practice sale and an unprepared one is not luck. It is 12 to 18 months of deliberate, structured work – the kind that removes buyer objections before they are raised, improves the EBITDA that drives your multiple, and positions your practice as the most attractive asset a buyer will see that year.

Exit Planning is part of Samera’s growth advisory cluster – we are your accountants and your financial strategists, not a broker. We start two years before you want to sell.

The financial reality

UK dental practices typically sell at a multiple of 4-7x EBITDA. The multiple you achieve depends almost entirely on how a buyer perceives your risk profile – and your preparation determines that perception.

0.5x EBITDA – the typical multiple difference between a well-prepared and an unprepared practice sale. On £200,000 EBITDA, that is £100,000 in additional proceeds.

We are not a generic M&A adviser. We are dental practice accountants who also own a dental group. We know what buyers pay premium multiples for – and what kills a deal at the eleventh hour.

Why preparation matters

Three truths every practice owner learns too late.

The dental practice M&A market is buyer-sophisticated. The more prepared you are, the more of your true value you capture.

Buyers are professionals. Most sellers are not.

Corporate acquirers, DSOs and their advisers evaluate practices every week. They have refined due diligence processes designed to identify risk – and to use every risk they find to negotiate your price down. Most practice owners face this once in their career. Preparation closes the knowledge gap.

The best financial years need to be recent.

Dental practice valuations are typically based on a three-year adjusted EBITDA average, weighted towards the most recent year. If your best financial performance was two years ago – because you reduced sessions, increased drawings or deferred income – buyers will anchor to the lower average. The preparation window matters enormously.

Small issues become big deductions at the deal stage.

A lease with four years remaining. A key associate without a contract. CQC compliance gaps. Equipment owned personally rather than by the practice. Each of these – invisible to you day to day – becomes a price chip in a buyer’s hands. Identifying and resolving them 18 months before your sale costs a fraction of what they will cost you at the negotiating table.

Before vs after

What buyers see

What your practice looks like to a buyer – prepared vs unprepared

These are the factors that determine whether a buyer offers you 4.5x or 6.5x EBITDA – and whether they move quickly to completion or use every delay to renegotiate. Samera’s role is to ensure you present as the practice in the right-hand column, before a buyer ever opens a data room.

Factor	Without preparation	With Samera Exit Accelerator
EBITDA record	Mixed, with principal cost distortions and inconsistent trends	Clean, normalised, showing a three-year upward trajectory
Associate contracts	Informal or unsigned; some verbal arrangements	Fully executed, IR35-reviewed and legally transferable to a buyer
Lease position	Short unexpired term; landlord relationship undefined	10-15 year lease secured with renewal options documented
NHS contract	Transfer risk unclear; clawback history undisclosed	Transferability confirmed; clean clawback record evidenced
Patient base	NHS-heavy, private income undocumented	Revenue mix clearly documented; recall system evidenced
Typical sale outcome	4.2-4.8x EBITDA; extended due diligence; price chips late	5.8-7.0x EBITDA; clean, fast, confident completion

Our process

The Samera Practice Exit Accelerator – five stages.

A structured 18-month programme that systematically transforms your practice into the most commercially attractive asset it can be – and ensures you achieve the highest price a motivated buyer in the current market will pay.

Stage 1 – Exit Readiness Audit

Timeframe: Months 1-2

Before any planning happens, we need to understand exactly where you stand. Samera conducts a 40-point Exit Readiness Audit across every dimension a buyer will scrutinise – financial, operational, legal and commercial.

This is not a superficial overview. We are examining your accounts and your practice through the eyes of a sophisticated acquirer and their due diligence team. We benchmark your EBITDA against peer practices in our 300+ client dataset, identify the specific factors most likely to suppress your multiple, and produce a written Exit Readiness Report that tells you exactly what a buyer will love, what they will question, and what they will attempt to use to drive your price down.

This report becomes the working document for everything that follows.

Key deliverables:

• 40-point Exit Readiness Report across financial, legal, operational and commercial dimensions
• EBITDA analysis – your current position compared to peer benchmarks, and the gap between reported and adjusted EBITDA
• Risk Register – every factor that could suppress your sale price, ranked by impact and urgency
• Indicative valuation range – see Practice Valuations for our formal valuation methodology
• Personalised 18-month action plan with prioritised steps and estimated value impact for each

Stage 2 – EBITDA Improvement Programme

Timeframe: Months 3-9

This is where the most significant financial value is created. Since dental practice valuations are driven by EBITDA multiples, every pound of sustainable EBITDA improvement is worth four to seven pounds in sale price. We work systematically through your cost structure, income mix and operational model to find and realise those improvements – before a buyer ever sees your numbers.

This is not about aggressive cost-cutting that damages the practice. It is about normalisation – removing distortions that suppress the reported profitability of an otherwise healthy business. Common examples include excessive principal drawings recorded as practice costs, personal expenditure running through the business, supplier contracts that have not been renegotiated in years, and revenue streams that are not recorded in a way that maximises their visibility to a buyer.

We also address income mix. A practice with 70% NHS income will attract a lower multiple than one with a growing, documented private patient base. We help you understand what changes to income mix are realistic and commercially valuable within your timeframe – and we document the trajectory in a way that tells a compelling story to buyers. Fee Review is typically the entry point for income-mix work; we coordinate that workstream as part of the programme.

Key deliverables:

• Monthly management accounts prepared to buyer-presentation standard throughout the programme
• Adjusted EBITDA schedule – a full normalisation of your accounts to remove non-recurring and personal items
• Cost base review – supplier renegotiation benchmarks, staffing efficiency analysis, lab and materials cost comparison against sector peers
• Income mix analysis and private revenue growth recommendations, documented in buyer-facing format
• Monthly EBITDA improvement tracker – progress monitored against the target valuation at every step

Stage 3 – Operational and legal risk removal

Timeframe: Months 4-12

A practice with strong EBITDA can still achieve a poor multiple if operational and legal due diligence reveals material risks. This stage runs in parallel with the EBITDA programme and systematically removes the non-financial risks that buyers use to negotiate price down – or to walk away entirely.

We work through your lease position (critical – a short or poorly structured lease can reduce your multiple by 0.5x or more on its own), your associate and staff contracts, your CQC compliance record, your NHS contract transferability, your equipment ownership structure, and your insurance and regulatory position.

For each risk identified in Stage 1, we develop a specific resolution strategy – and we ensure that resolution is properly documented and evidenced in a form that satisfies buyer due diligence.

Key deliverables:

• Lease review and negotiation strategy – renewal approach, landlord engagement plan, documented options to extend
• Associate and staff contract audit – confirming every key clinical relationship is formally documented, IR35-reviewed and transferable
• CQC compliance review – identifying and resolving any regulatory gaps before they surface in due diligence
• NHS contract transferability assessment – what transfers automatically, what requires NHS England consent, and the realistic timeline
• Equipment and asset register – ensuring ownership is correctly structured to maximise buyer confidence and asset value

Stage 4 – Sale preparation and buyer identification

Timeframe: Months 12-15

By this stage, your practice has been transformed into a well-documented, low-risk, high-EBITDA asset ready for market. Stage 4 prepares the materials that will represent your practice to buyers – and identifies the right buyers for your specific practice.

We prepare a comprehensive Information Memorandum – the document every serious buyer will want to see. Written to professional M&A standards, it presents your financial performance, clinical capability, operational model, location, staff profile and growth opportunities in the most compelling terms. This is not the summary sheet a practice broker produces in an afternoon. It is a detailed, evidenced document that positions your practice as a premium acquisition in a competitive market.

We then identify the right buyer universe – corporate DSOs, individual dentist acquirers, private equity-backed groups, or strategic acquirers. Different buyers value different characteristics, and we ensure your practice reaches the buyers most likely to pay a premium for what makes it distinctive. We work alongside specialist dental practice agents (such as Christie and Co) where a broad market approach is appropriate – or run a more targeted process where that better suits your practice.

Key deliverables:

• Professional Information Memorandum – prepared to institutional M&A standards, not estate agent standard
• Financial data pack – three-year accounts, management accounts and adjusted EBITDA schedule in buyer-ready format
• Buyer universe mapping – identifying and prioritising the right acquirers for your specific practice type and geography
• Non-Disclosure Agreement template – ensuring confidentiality is protected throughout the process
• Data room setup – a structured, secure repository of all due diligence materials, ready to open when a qualified buyer is identified

Stage 5 – Transaction management and completion

Timeframe: Months 15-18

The transaction stage is where preparation pays off. A well-prepared practice with clean due diligence, a professional information memorandum and a fully evidenced financial record moves through the sale process significantly faster – and with significantly less price chipping – than an unprepared one.

We are with you at every step. We support buyer negotiations from an informed position – because we know your numbers at the level of detail that gives you genuine confidence at the table. We coordinate with your solicitors on heads of terms, the sale and purchase agreement, and the post-completion arrangements.

Through Samera Finance (FCA-regulated), we can also support the buyer’s acquisition financing – a meaningful commercial advantage that keeps transactions moving cleanly to completion. Post-completion, we advise on the tax treatment of your proceeds, any earnout arrangements and the personal financial planning implications – working with you to ensure the value you have built is fully protected.

For owners who want a brokered sale rather than a structured exit programme, our Sell a Practice service is the entry point.

Key deliverables:

• Negotiation support – Samera present or advising at all commercial negotiation conversations
• Heads of Terms review – ensuring commercial terms reflect the preparation work and protect your position
• Due diligence management – coordinating all responses to buyer queries from the prepared data room
• Buyer finance introduction via Samera Finance – keeping the deal moving if the buyer requires acquisition finance
• Tax planning on sale proceeds – capital gains structuring, Business Asset Disposal Relief review, and post-completion personal financial planning

See if your practice is ready

Free 30-minute consultation with Arun to talk through where you stand and what the right next step is.

Why Samera

The only adviser who has sat on both sides of the table.

Samera’s positioning in this market is unusual. No other adviser combines all four of the following elements – and every one of them changes the quality of advice you receive.

We are already your accountant

We know your EBITDA, your cost structure, your associate arrangements and your financial history at the level of detail no broker starts with. This is not a service that begins with due diligence – it begins with years of deep financial knowledge. We see your practice the way a buyer’s accountant will see it. We fix it first.

We own a dental group ourselves

Arun Mehra co-founded the Neem Tree Dental Group in London (Wandsworth and Esher). We have not just advised on practice acquisitions – we have made them. We understand the operational reality, the staffing dynamics and the commercial drivers of practice value from an owner’s perspective. That changes how we advise you.

Finance brokerage in-house

Through Samera Finance (FCA-regulated, FRN 757431), we can introduce acquisition finance to your buyer. A buyer with finance already arranged moves significantly faster to completion than one who must arrange it independently. Our in-house brokerage capability keeps your transaction clean and reduces the risk of late-stage delays and re-negotiations.

Data from 1000+ dental practices

We work with over 1000 UK dental practices. That dataset gives us an authoritative, real-world view of what strong EBITDA looks like, what multiples comparable practices are achieving right now, and what factors are consistently driving value in the current market. We advise from evidence, not assumption.

Common mistakes

Seven mistakes that cost dental practice owners money.

In 25 years of specialist dental accountancy, these are the mistakes we see most consistently – and most expensively. Each one is avoidable with proper preparation.

Investment

How to work with Samera on your practice exit

We offer three ways to engage, depending on where you are in your exit timeline and what level of support you need.

Reviews

Speak to the team

FAQs

Related services

Related reading

Guides to selling and growing a dental practice